Bcl-2 family member Mcl-1 expression is reduced under hypoxia by the E3 ligase FBW7 contributing to BNIP3 induced cell death in glioma cells-Reference-Cited by-同舟云学术

Bcl-2 family member Mcl-1 expression is reduced under hypoxia by the E3 ligase FBW7 contributing to BNIP3 induced cell death in glioma cells

Published:2015-10-15 Issue:6 Volume:17 Page:604-613
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Chen Yongqiang,Henson Elizabeth S.,Xiao Wenyan,Shome Epsita,Azad Meghan B.,Burton Teralee R.,Queau Michelle,Sathya Akshay,Eisenstat David D.,Gibson Spencer B.

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/15384047.2015.1095399

Reference37 articles.

1. Brain and other central nervous system tumors: rates, trends, and epidemiology

2. Treatment options for glioblastoma

3. The 2007 WHO Classification of Tumours of the Central Nervous System

4. Mcl-1 is a potential therapeutic target in multiple types of cancer

5. Myeloid Cell Leukemia-1 Inversely Correlates with Glycogen Synthase Kinase-3β Activity and Associates with Poor Prognosis in Human Breast Cancer

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomimetic three-dimensional glioma model printed in vitro for the studies of glioma cells and neurons interactions;International Journal of Bioprinting;2023-08-16

2. The roles of ubiquitination‐mediated intrinsic apoptotic signalling in cancer therapy;Clinical and Translational Discovery;2022-06

3. Bcl-2 interacting protein 3 (BNIP3) promotes tumor growth in breast cancer under hypoxic conditions through an autophagy-dependent pathway;Bioengineered;2022-02-24

4. Phragmunis a suppresses glioblastoma through the regulation of MCL1-FBXW7 by blocking ELK1-SRF complex-dependent transcription;Neurochemistry International;2021-07

5. Targeting the Ubiquitin System in Glioblastoma;Frontiers in Oncology;2020-11-25